Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
García-Carracedo D, Villaronga MÁ, Álvarez-Teijeiro S, Hermida-Prado F, Santamaría I, Allonca E, Suárez-Fernández L, Gonzalez MV, Balbín M, Astudillo A, Martínez-Camblor P, Su GH, Rodrigo JP, García-Pedrero JM.
García-Carracedo D, et al.
Oncotarget. 2016 May 17;7(20):29780-93. doi: 10.18632/oncotarget.8957.
Oncotarget. 2016.
PMID: 27119232
Free PMC article.